Want to see QNTM full AI Analyst Report?
Quantum Biopharma (QNTM) Income Statement
Quantum Biopharma Income Statement
Last quarter (Q2 2026), Quantum Biopharma's total revenue was $0.00. In Q2, Quantum Biopharma's net income was $-3.17M. See Quantum Biopharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 15.30M | $ 16.14M | $ 23.79M | $ 27.43M | $ 33.74M | |
| Depreciation and Amortization | $ 545.78K | $ 490.57K | $ 2.51M | $ 4.53M | $ 4.05M |
| $ -25.79M | $ -14.38M | $ -15.72M | $ -22.12M | $ -29.82M | |
| $ -15.30M | $ -16.14M | $ -23.79M | $ -27.43M | $ -33.74M | |
| $ -11.65M | $ 1.22M | $ 5.56M | $ 725.95K | $ -194.30K | |
| $ -26.96M | $ -14.92M | $ -18.23M | $ -26.70M | $ -33.94M | |
| $ -26.18M | $ -14.20M | $ -17.90M | $ -23.61M | $ -35.29M | |
| Per Share Metrics | |||||
| Basic EPS | $ -8.11 | $ -12.49 | $ -29.39 | $ -39.62 | $ -65.63 |
| Diluted EPS | $ -8.11 | $ -12.49 | $ -29.39 | $ -39.62 | $ -65.63 |
| Weighted Average Shares Outstanding | 3.29M | 1.14M | 609.06K | 595.88K | 537.62K |
| Weighted Average Shares Outstanding (Diluted) | 3.29M | 1.14M | 609.06K | 595.88K | 537.62K |
Currency in CAD